Trpa1

Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Wasabi receptor)

Spatial tier: REGION_BIASED · Class: ION_CHANNEL · Top region: RL (Rostral linear nucleus raphe) · Positive regions: 31/554

45.6Discovery Score
33.7Targetability Score
CEvidence grade C
What this means: Trpa1: fine CCF profile is region-biased toward RL (top regions: RL, VMH, SCdg, EPv, DMH); this is a discovery lead, not direct proof.

Function in RL: evidence, prediction, innovation

Gene function
TRPA1 is a calcium-permeable, non-selective cation channel of the TRP family with a long ankyrin-repeat N-terminus. It is the 'wasabi receptor': electrophilic irritants, reactive oxygen and lipid-peroxidation products such as acrolein and 4-HNE covalently modify cysteines in the channel and open it, causing calcium influx and depolarisation. It is best known in nociceptors but is also expressed by some central neurons and glia.
Region function
The rostral linear nucleus of the raphe is a midline midbrain nucleus of the A10 dopamine group, adjacent to the VTA; its dopaminergic and glutamatergic neurons project to extended amygdala, septum and hypothalamus and contribute to reward, stress and anxiety-like behaviour.
Published in this region
inferred No region-specific literature found. The closest relevant finding is that TRPA1 is functional in central neurons and senses the local chemical microenvironment: Kawabata 2023 showed TRPA1 in anterior cingulate cortex acts as an oxygen/hypoxia sensor that modulates neural activity; work on midbrain dopamine neurons has examined TRPA1 only in the context of acrolein-driven degeneration (Shi 2021).
Predicted function
Prediction: TRPA1 in rostral linear raphe dopamine neurons would act as a metabolic/oxidative-stress sensor that converts local hypoxia, reactive oxygen species or lipid peroxidation products into tonic calcium entry and depolarisation, raising dopamine output to extended amygdala under stress. Local TRPA1 agonist (AITC) should excite these cells and increase anxiety-like behaviour, while HC-030031 or A-967079 blockade and Trpa1 knockout are predicted to reduce stress-evoked dopamine release and protect these neurons from oxidative insult.
Innovation
★★★★★ 5/5 TRPA1 is almost entirely a peripheral-nociceptor field; its presence in an A10 midline dopamine nucleus is a genuinely unexplored central role.
Tools
Agonists allyl isothiocyanate and cinnamaldehyde; antagonists HC-030031 and A-967079; Trpa1 knockout and Trpa1-Cre/reporter mice; dopaminergic targeting with DAT-Cre or TH-Cre in the linear raphe.
References

Direct evidence located at the region

Trpa1 Allen ISH at the CCF centroid of RL

Allen ISH experiment 70230939, section image 70006732 (section 146): the section that contains the CCF centroid of Rostral linear nucleus raphe according to the Allen image-to-atlas alignment (reference_to_image), with a 2 mm window around that point. Left: whole section, red box = window. Middle: ISH signal. Right: Allen's expression-mask view of the same window. open this image in the Allen viewer

Direct spatial evidence

MERFISH REGION LOCATOR
RL MERFISH region locator
Real single-cell MERFISH coordinates for the RL (Rostral linear nucleus raphe) section -- our own ground-truth data, showing exactly where this region sits, independent of whether the Allen ISH section below is easy to read.

Regional expression figure

Trpa1 regional expression profile

Predicted WMB × fine-CCF profile; not direct full-transcriptome spatial measurement.

Spatial profile

RL
0.134
VMH
0.123
SCdg
0.112
EPv
0.0892
DMH
0.0844
AIp5
0.0803
DG-po
0.0798
PAA
0.0759
IF
0.0755
CA3slm
0.0707
PVp
0.0655
EW
0.0643
AHN
0.0639
SCiw
0.0635
SCdw
0.0622
PIR
0.0619
VISpor4
0.0614
TU
0.0613
DR
0.0604
BMAa
0.0584

Evidence and specificity

Evidence status
PREDICTED_FINE
Direct sources
None; predicted localization only
Exclusive threshold
12 positive regions out of 554
Spatial specificity
0.305
Top-region fraction
0.049
Filter status
PASS

Interpretation limits